UK Research and Innovation seeks to establish a director-led institute advancing mechanistic biomedical research into obesity and related diseases through the UK Obesity Research Institute.
Funder: UK Research and Innovation
Due Dates: November 19, 2026: Full application submission deadline
Funding Amounts: Up to £72 million over 7 years (80% FEC; up to £90M total project cost); one institute award expected
Summary: Major, director-led funding to establish a UK Obesity Research Institute advancing mechanistic biomedical research into obesity and related diseases.
Key Information: Only one application per lead organisation; international co-leads allowed under specific rules.
This opportunity, funded by UK Research and Innovation (UKRI) through the Medical Research Council (MRC) and co-funded by the British Heart Foundation (BHF), aims to establish a world-leading, collaborative UK Obesity Research Institute (UK-ORI). The institute will focus on the mechanistic biomedical drivers of obesity and related cardiometabolic diseases, integrating fundamental biomedical science, medicine, and technological innovation to accelerate prevention and treatment strategies. The initiative seeks a director-led application, supported by a multidisciplinary leadership team, to deliver transformative health impact and position the UK as a global leader in obesity research.